Ensysce Biosciences, Inc.

ENSC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Jun 2, 2023
POS EX May 17, 2023
AW May 17, 2023
10-Q May 15, 2023
8-K May 15, 2023
424B3 May 12, 2023
424B3 May 12, 2023
424B3 May 12, 2023
424B3 May 12, 2023
POS AM May 12, 2023
EFFECT May 9, 2023
CORRESP May 9, 2023
CORRESP May 9, 2023
S-1/A May 9, 2023
S-1/A May 8, 2023
UPLOAD May 4, 2023
S-1 Apr 28, 2023
8-K Apr 10, 2023
8-A12G/A Mar 31, 2023
8-K Mar 31, 2023
10-K Mar 30, 2023
8-K Mar 30, 2023
8-K Mar 24, 2023
4 Mar 6, 2023
4 Mar 2, 2023
← Newer Page 7 of 22 · 546 filings Older →